CMPS vs ASTH

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 02, 2026

CMPS

40.7
AI Score
VS
ASTH Wins

ASTH

53.8
AI Score

Investment Advisor Scores

CMPS

41score
Recommendation
HOLD

ASTH

54score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric CMPS ASTH Winner
Forward P/E 0 8.9686 Tie
PEG Ratio 0 0 Tie
Revenue Growth 0.0% 48.5% ASTH
Earnings Growth 0.0% 110.5% ASTH
Tradestie Score 40.7/100 53.8/100 ASTH
Profit Margin 0.0% 1.1% ASTH
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

CMPS 1M: -10.1% · 3M: -7.3% ASTH 1M: -7.0% · 3M: -23.5%

Current Technical Phase

CMPS

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 35

RSI (14): 34.9 · Price: $11.90

ASTH

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 47

RSI (14): 47.3 · Price: $35.88

Fundamentals Snapshot

Metric CMPS ASTH
Market Cap — —
Forward P/E -8.3 9.9
Trailing P/E — 43.1
Revenue (TTM) — —
Revenue Growth 0.0% 0.5%
Gross Margin — 0.1%
Operating Margin 0.0% 0.0%
EPS -3.79 0.81
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, ASTH is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.